Cargando…
Tumor targeting of innate and adaptive immunity by the adoptive cell transfer of engineered T lymphocytes co-expressing iNKT and tumor-specific MHC-I TCRs
Autores principales: | Tschumi, Benjamin O, Iwaszkiewicz, Justyna, Zhang, Lianjun, Corgnac, Stéphanie, Mach, Jean-Pierre, Romero, Pedro, Donda, Alena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288397/ http://dx.doi.org/10.1186/2051-1426-2-S3-P11 |
Ejemplares similares
-
iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine
por: Corgnac, Stéphanie, et al.
Publicado: (2014) -
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses
por: Corgnac, Stéphanie, et al.
Publicado: (2012) -
Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
por: Aoki, Takahiro, et al.
Publicado: (2023) -
Development of genetically engineered iNKT cells expressing TCRs specific for the M. tuberculosis 38-kDa antigen
por: Jiang, Zhen-Min, et al.
Publicado: (2015) -
iNKT and MAIT Cell Alterations in Diabetes
por: Magalhaes, Isabelle, et al.
Publicado: (2015)